Are Canadian Cannabis Stocks Ready to Rebound? 3 Names to Watch

The Canadian cannabis sector continues to evolve in early 2026. Although volatility remains, investor interest is returning. Regulatory discussions in the United States are once again gaining momentum. Because of that, Canadian operators with U.S. exposure are drawing attention. Many investors are watching companies positioned for cross-border expansion.

Is It Time to Dump Your Shares of Tilray?​

Tilray has destroyed shareholder value with excessive dilution over the years. There doesn't seem to be enough growth to hope for a dramatic turnaround.

The Motley Fool • Feb 23, 2026

Here's Why I Wouldn't Touch Tilray With a 10‑Foot Pole

Tilray Brands is best known for its marijuana products. But the company has acquired 19 brands since 2021.

The Motley Fool • Feb 23, 2026

Don't Even Think About Buying Tilray Stock Until You Read This Warning

Tilray has been expanding beyond marijuana to include hemp products and alcoholic beverages. The company's strategy has led to top-line growth, but it has yet to generate sustainable profits.

The Motley Fool • Feb 22, 2026

Canopy Growth or Tilray Brands: Which Stock Is More Likely to Be a Millionaire Maker?

Both companies have positioned themselves to capitalize on potential opportunities in the cannabis market. However, there is significant uncertainty ahead, due to regulatory issues (and other concerns) in the industry.

The Motley Fool • Feb 20, 2026

Canadian Marijuana Stock Picks For Investors 2026

There have been many changes and phases to legal cannabis around the globe. With the USA being the biggest market and Canada becoming the first to outright legalize the plant. This has been a slow uphill climb as laws and regulatory matters have made things anything but easy. However, this has not deterred potential investors from seeing an opportunity. Marijuana stocks have offered the average investor or person a chance to enter the space.

Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), a leading global consumer packaged goods company and the fourth-largest craft beer brewer in the United States, today announced that it has entered into an exclusive licensing agreement starting January 1, 2027 with the Carlsberg Group, one of the world's premier brewing organizations and among the largest globally by revenue.

GlobeNewsWire • Feb 18, 2026

Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals

NEW YORK and LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that its European pharmaceutical distribution business, CC Pharma, has entered into a strategic agreement with Smartway Pharmaceuticals, a leading UK-based pharmaceutical distribution partner, to expand the availability of pharmaceutical products across the United Kingdom. Through this agreement, CC Pharma and Smartway will jointly support the expansion of parallel import and specialist pharmaceutical supply in the UK, leveraging Smartway's established national distribution infrastructure to facilitate the delivery of pharmaceutical products and CC Pharma's European procurement capability and GMP capacity, marking a notable advancement in Tilray's comprehensive European medical expansion strategy.

GlobeNewsWire • Feb 12, 2026

Is Tilray Stock Going to $0?

Tilray Brands has struggled to stay out of the red over the years, and that pattern may continue for the foreseeable future. The company's growth prospects are underwhelming.

The Motley Fool • Feb 10, 2026

Tilray's CC Pharma Recognized as a TOP 100 Innovator in Germany

DENSBORN, Germany, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that CC Pharma, its European pharmaceutical distribution business, has been named a  TOP 100 Innovator in Germany , one of the country's most respected and independent recognitions for innovation among small and mid-sized enterprises. CC Pharma operates a nationwide pharmaceutical distribution network serving more than 13,000 pharmacies across Germany, providing reliable access to a broad portfolio of prescription and over-the-counter medicines.

GlobeNewsWire • Feb 4, 2026